In the biological processe of “regulation of MAP kinase activity”, we enriched the gene “PAK1”, the previous study had shown that the PAK1 activation was able to attenuate hypertrophy and offered a novel therapeutic strategy for the CH [17]. Here, PAK1 is linked to cyclic hematopoiesis.